Form 4 for AXGN Axogen, Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0000805928-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | 2022-02-15 | AXGN | Billet Isabelle | Chief Strategy, BD Off | A - Grant | $0.00 | +1,325 | 16.2K | +9% | $0 | |
| 2022-02-17 | 2022-02-15 | AXGN | Billet Isabelle | Chief Strategy, BD Off | F - Tax | $8.42 | -447 | 15.7K | -3% | -$3,764 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | A | A | 1,325 | $0.00 | 16,163 | D | — | — | (F1) This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria. (F2) Includes 654 shares acquired under the Axogen stock purchase plan on December 31, 2021. |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 447 | $8.42 | 15,716 | D | — | — | (F3) The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022. |